FATE 8-K 2026-08-13

FATE THERAPEUTICS INC (FATE) 8-K dated 2026-08-13 — accession 0001193125-26-347984. This URL is the filing, not the FATE hub.

FATE THERAPEUTICS INC (FATE) is a biotechnology company listed on US.

FATE THERAPEUTICS INC filed a 8-K on 2026-08-13. Accession 0001193125-26-347984.

Cached items: 2.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported FATE revenue for 2026-06-30 was $3.4M. Net income was -$61.4M. FATE currently screens at market cap $331.0M.

Not investment advice. The FATE SEC hub lists recent forms. The stock page is the research view.